Patient Experience Linked to Urologic CA Surgical Outcomes

This article originally appeared here.
Share this content:
Patient Experience Linked to Urologic CA Surgical Outcomes
Patient Experience Linked to Urologic CA Surgical Outcomes

THURSDAY, June 9, 2016 (HealthDay News) -- Patient experience is associated with urologic cancer surgical outcomes, according to a study published online June 2 in Cancer.

For the study, Joseph D. Shirk, M.D., from the University of California at Los Angeles, and colleagues used data from the Nationwide Inpatient Sample and Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) from 2009 to 2011. Hospital admissions for cancer-directed prostatectomy, nephrectomy, and cystectomy were identified, and mortality, length of hospitalization, discharge disposition, and complications were assessed. The likelihood of selected outcomes was compared between the top and bottom tercile hospitals using mixed effect models.

The researchers observed small differences in patient age, race, income, comorbidity, cancer type, receipt of a minimally invasive surgery, and procedure acuity according to HCAHPS tercile in a sample of 46,988 encounters (P < 0.001). There was variation in hospital characteristics based on ownership, teaching status, size, and location (P < 0.001). Patients treated in high-performing hospitals less frequently faced prolonged hospitalization or nursing-sensitive complications compared with those treated in low-performing hospitals (odds ratios, 0.77 and 0.85, respectively). There was no difference in terms of inpatient mortality, other complications, or discharge disposition (P > 0.05).

"For urologic cancer surgery, patient experience may be optimally viewed as an independent quality domain rather than a mechanism with which to improve surgical outcomes," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »